Zsolt Talloczy
Impact in
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Spondyloarthritis Studies and Treatments 7
- Rheumatoid Arthritis Research and Therapies 6
- Surgery 3
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- Brian Porter (6 shared papers)Atul Deodhar (5 shared papers)Jürgen Braun (4 shared papers)Xenofon Baraliakos (4 shared papers)Anastasia Lesogor (4 shared papers)Alan Kivitz (4 shared papers)Eumorphia Maria Delicha (2 shared papers)R. Scott Wright (2 shared papers)
- Journals
- Lara D. Veeken (2 papers)Circulation (1 paper)Frontiers in Immunology (1 paper)Cardiovascular Research (1 paper)Rheumatology and Therapy (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Zsolt Talloczy
10 papers receiving 601 citations
Zsolt Talloczy's Hit Papers
Peers
Comparison fields: 5 of 54
- Rheumatology 300
- Immunology 268
- Hematology 135
- Surgery 221
- Economics and Econometrics 84
Countries citing papers authored by Zsolt Talloczy
This map shows the geographic impact of Zsolt Talloczy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsolt Talloczy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsolt Talloczy more than expected).
Fields of papers citing papers by Zsolt Talloczy
This network shows the impact of papers produced by Zsolt Talloczy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsolt Talloczy. The network helps show where Zsolt Talloczy may publish in the future.
Co-authors
The 25 scholars most cited alongside Zsolt Talloczy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial Hit paper breakdown → | 2023 | 193 |
| 2 | 2018 | 106 | |
| 3 | 2018 | 83 | |
| 4 | Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. | 2017 | 69 |
| 5 | 2019 | 64 | |
| 6 | 2023 | 45 | |
| 7 | 2024 | 38 | |
| 8 | 2021 | 4 | |
| 9 | 2022 | 4 | |
| 10 | 2020 | 3 | |
| 11 | 2019 | 0 |
About Zsolt Talloczy
Zsolt Talloczy is a scholar working on Rheumatology, Surgery, Hematology, Economics and Econometrics and Immunology, having authored 11 papers that have together received 609 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Lipoproteins and Cardiovascular Health (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Pharmaceutical Economics and Policy (2 papers), Gout, Hyperuricemia, Uric Acid (1 paper) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Rheumatology (300 citations), Immunology (268 citations), Hematology (135 citations), Surgery (221 citations) and Economics and Econometrics (84 citations). Zsolt Talloczy has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Brian Porter, Atul Deodhar, Jürgen Braun, Xenofon Baraliakos, Anastasia Lesogor, Alan Kivitz, Eumorphia Maria Delicha, R. Scott Wright, Ulf Landmesser and Lawrence A. Leiter. Their work appears in journals such as Lara D. Veeken, Circulation, Frontiers in Immunology, Cardiovascular Research and Rheumatology and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.